2017-04-24 16:12:28 UTC 0 Comments

AltraBio's work in collaboration with the Swiss company Actelion Pharmaceuticals Ltd was highlighted by a scientific publication in "ERJ Open Research". This work, named "MMP-7 is a predictive biomarker of disease progression in patients with idiopathic pulmonary fibrosis", consisted in the characterization of blood biomarkers associated with idiopathic pulmonary fibrosis. Congratulations to Dr. Yasmina Bauer and to all who contributed to this work.

New Comment